Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07827183) titled 'AI-Personalized Discharge Education for Patients After Lung Cancer Surgery' on Sept. 14.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Single (Outcomes Assessor).

Primary Sponsor: Xiamen University

Condition: Lung Cancer (Diagnosis)

Intervention: Behavioral: AI-Personalized Discharge Education

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: August 15, 2026

Target Sample Size: 156

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07827183

Pub...